# Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.

> **NCT06154018** · NA · COMPLETED · sponsor: **University of Ioannina** · enrollment: 98 (actual)

## Conditions studied

- Cardiac Surgery
- CAD
- Valve Heart Disease
- Coagulation Disorder

## Interventions

- **DRUG:** Protamin

## Key facts

- **NCT ID:** NCT06154018
- **Lead sponsor:** University of Ioannina
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-18
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2024-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06154018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06154018, "Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06154018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*